A-PBITMO

Identifiers
IUPAC name (Adamantan-1-yl)(3-pentyl-2-thioxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)methanone
CAS Number	none
Chemical and physical data
Formula	C23H30N2OS
Molar mass	382.57 g·mol−1
3D model (JSmol)	Interactive image
SMILES S=C1N(C(=O)C23CC4CC(C2)CC(C3)C4)c2ccccc2N1CCCCC
InChI InChI=1S/C23H30N2OS/c1-2-3-6-9-24-19-7-4-5-8-20(19)25(22(24)27)21(26)23-13-16-10-17(14-23)12-18(11-16)15-23/h4-5,7-8,16-18H,2-3,6,9-15H2,1H3 Key:VUROLZZLDVMOQX-UHFFFAOYSA-N

A-PBITMO is asynthetic cannabinoid receptor agonist that has been sold as adesigner drug, first reported in Germany in July 2023,^[1] and also subsequently identified in Russia.^[2] It has an unusual 1,3-dihydrobenzimidazole-2-thione core structure which has not previously been seen in cannabinoid designer drugs.

• A-PONASA
• AB-001
• AM-1248
• APINACA
• FUBIMINA
• PF-03550096

Thiscannabinoid related article is astub. You can help Wikipedia byexpanding it.

• v
• t
• e

• Cannabinoids
• Designer drugs
• Adamantanes
• Thioureas
• Benzimidazoles
• Cannabinoid stubs

• CS1 Russian-language sources (ru)
• Articles with short description
• Short description matches Wikidata
• Short description is different from Wikidata
• Chemicals that do not have a CAS registry number assigned
• Articles without EBI source
• Chemical pages without ChemSpiderID
• Chemical pages without DrugBank identifier
• Articles without KEGG source
• Articles without UNII source
• Drugs missing an ATC code
• Drugs with no legal status
• Articles containing unverified chemical infoboxes
• All stub articles